Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma

Table 4 The RCC-specific mean survivals for myosin VI, E-cadherin and beta-catenin immunostaining.

Marker	Immunostaining result	Mean survival (months)	95% CI	p-value
Cytoplasmic myosin VI	negative	162	137-187	0.3
	positive	146	128-163
Nuclear myosin VI	negative	151	134-169	0.9
	positive	141	118-164
Membranous E-cadherin	negative	153	138-168	0.3
	positive	113	73-152
Nuclear E-cadherin	negative	144	124-164	0.4
	positive	158	137-179
Cytoplasmic beta-catenin	negative	152	137-167	0.5
	positive	128	81-174
Nuclear beta-catenin	negative	143	124-163	0.3
	positive	157	136-178

P values presented were produced with the log rank test. CI, confidence interval.

ISSN: 1756-9966